Arix Bioscience plc (LON:ARIX)is the topic of conversation when Hardman and Co’s Analyst Martin Hall caught up with DirectorsTalk for an exclusive interview. Q1: Can you tell us what Arix ...

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Dr Martin Hall, Analyst at Hardman & Co joins DirectorsTalk. Martin explains how Arix differs from other investment vehicles, how ...

Arix Bioscience plc (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage ...

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage ...

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage ...

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage ...

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Hardman and Co’s Analyst Dr Dorothea Hill caught up with DirectorsTalk for an exclusive interview. Q1: You recently initiated on ...

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Dr Dorothea Hill, Analyst at Hardman & Co joins DirectorsTalk. Having recently initiated on Arix Bioscience Dorothea explains the key ...

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage ...